235
Participants
Start Date
July 31, 2001
Primary Completion Date
December 31, 2002
Study Completion Date
December 31, 2002
activated recombinant human factor VII
An initial bolus dose of 50 mcg/kg body weight (BW) followed by 50 mcg/kg BW every second hour until completion of surgery
activated recombinant human factor VII
An initial bolus dose of 100 mcg/kg body weight (BW) followed by 100 mcg/kg BW every second hour until completion of surgery
placebo
An initial placebo bolus dose followed by placebo every second hour until completion of surgery
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Bangkok
Novo Nordisk Investigational Site, Beijing
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Beijing
Lead Sponsor
Novo Nordisk A/S
INDUSTRY